Chongqing Junyao Biopharmaceutical

Chongqing Junyao Biopharmaceutical is a pharmaceutical company based in Chongqing, China, specializing in the development and registration of chemical drugs. The company focuses on a diverse range of therapeutic areas, including cardiovascular, respiratory, anti-infective, and pain management. Its pipeline features several products in the marketing application (NDA/ANDA) stage, such as Beraprost Sodium for pulmonary hypertension, Acetylcysteine for respiratory conditions, and Loxoprofen Sodium for pain management. Additionally, Chongqing Junyao is engaged in innovative formulation research, as demonstrated by its patent filings for novel crystalline forms of Ferric Maltol. The company operates primarily through a virtual R&D model, collaborating with manufacturing partners for clinical supply and commercial production.